Company profile: Echelon Biosciences
1.1 - Company Overview
Company description
- Provider of tools and reagents for biomedical research and drug discovery, including Membrane Lipid Strips for protein-lipid interaction assays; PIP3 Mass ELISA for PI(3,4,5)P3 detection; lipid antibodies; Hyaluronidase Activity ELISA; neuroscience resources for nervous system studies; and cell membrane resources for lipid-protein interactions and membrane analysis.
Products and services
- Lipid Antibodies: Lipid-specific reagents target phosphoinositides and disease-associated species such as S1P and LPA for precise recognition in biochemical assays
- Membrane Lipid Strips: Protein-lipid overlay membranes determine how proteins interact with lipids, visualized by antibody-based detection methods for assessing binding and specificity
- PIP3 Mass ELISA: 96-well ELISA detects PI(3,4,5)P3 extracted from cells without radioactive labeling, enabling measurement in cellular extracts
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Echelon Biosciences
BioSeek
HQ: United States
Website
- Description: Provider of cell-based human disease models for drug discovery and development, offering BioMap Systems—human primary cell-based assay systems for indications in vascular inflammation, cardiovascular and respiratory diseases, and fibrosis—and programs for the discovery of lead compounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioSeek company profile →
Ra Pharma
HQ: United States
Website
- Description: Provider of Cyclomimetics, a new drug class combining the diversity and specificity of antibodies with the benefits of small molecules; leveraging rapid generation of drug candidates to build a portfolio and partnerships focused on intracellular protein-protein interactions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ra Pharma company profile →
Lucy Therapeutics
HQ: United States
Website
- Description: Provider of mitochondrial-based small molecule therapies targeting mitochondrial dysfunction to treat complex diseases with a focus on neurological disorders; diagnostic biomarkers for disease diagnosis and progression monitoring; lead programs in Parkinson's disease and Rett syndrome; and early discovery efforts for undisclosed targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lucy Therapeutics company profile →
Pressure BioSciences
HQ: United States
Website
- Description: Provider of proprietary laboratory instrumentation and consumables: Pressure Cycling Technology (PCT) for controlled biomolecular interactions (cell lysis, biomolecule extraction) in biomarker discovery, drug design and forensics; BaroFold for high-pressure protein disaggregation/refolding to remove aggregates and enhance product safety and efficacy; and Ultra Shear Technology (UST) to make stable nanoemulsions, improving solubility and stability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pressure BioSciences company profile →
ThermoGenesis
HQ: United States
Website
- Description: Provider of automated technologies for cell-based therapeutics and bioprocessing, including BioArchive for computer-controlled preservation of cells with traceability; X-LAB for rapid, closed-system mononuclear cell isolation; PXP-1000 for automated cord blood stem cell processing; 3D Bag Set for buffy coat transfer with sterile cryoprotectant addition for long-term storage; and cleanroom and wet lab facilities for life science startups.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ThermoGenesis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Echelon Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Echelon Biosciences
2.2 - Growth funds investing in similar companies to Echelon Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Echelon Biosciences
4.2 - Public trading comparable groups for Echelon Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →